Matthew Kelling, DO
Cardiovascular Disease · Kansas City, KSNPI 1144725144
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by Abbott at 37.6% of the total. Reporting peaked in 2023 at $2,563 and has fallen 87.0% since, to $333 in 2025.
Across 63 payments — averaging $96.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Biotronik Inc.$2K
- Boston Scientific$436
- Amgen$431
- Medtronic$430
- Teleflex LLC$127
- plus $211 from 5 others
What the payments were for
- Travel & lodging$2,83647%
- Food & beverage$3,25753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 18 | $2,294 |
| Biotronik Inc. | 18 | $2,165 |
| Boston Scientific | 4 | $436 |
| Amgen | 10 | $431 |
| Medtronic | 4 | $430 |
| Teleflex LLC | 1 | $127 |
| Merck | 3 | $124 |
| Pfizer | 2 | $31 |
| Novo Nordisk | 1 | $25 |
| Bayer | 1 | $17 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$1,515
- Acticor$1,396
- Edora$1,396
- Rivacor$1,045
- Solia$748
- BioMonitor$748
- Sentus$648
- Plexa$648
- Repatha$230
- WATCHMAN Access System$145
- GENERAL ATHERECTOMY$139
- SYNERGY$136
- QuikClot$127
- Assurant Cobalt$125
- CARDIOMEMS$123
- ASSURITY$115
- SPRINTER LEGEND$107
How this compares
$6,093 in reported general payments places this provider in the 75th percentile of 175 cardiovascular disease providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Kansas City
- Timothy BeaverKansas City$22K
- Jayant NathKansas City$18K
- Donald McSweynKansas City$12K
- Jean-Alfred ThomasKansas City$11K
- Seyedhamed HosseinidehkordiKansas City$8K
- Mohammad AlarfajKansas City$7K
- Justin UgwuKansas City$5K
- Jonathan FreemanKansas City$4K
- Abdulrahman MoradKansas City$4K
- Siva TaduruKansas City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.